Journal List > Korean J Leg Med > v.44(1) > 1143453

Park, Koo, and Lee: Usefulness of Mast Cell Tryptase Analysis for Postmortem Diagnosis of Anaphylactic Shock

Abstract

Anaphylactic shock (AS) is a systemic and life-threatening type I hypersensitivity reaction and is often encountered at an autopsy. However, postmortem diagnosis of AS can be difficult due to non-specific autopsy findings. Clinically, the analysis of serum mast cell tryptase (MCT) is well known as a useful ancillary test for the diagnosis of AS. However, in order to apply this test to forensic autopsy, it is necessary to confirm its usefulness due to postmortem changes. We carried out serum MCT analysis in 299 autopsy cases including nine AS cases at National Forensic Service from January 2013 to May 2015 and analyzed the difference according to the cause of death and degree of postmortem change. As a result, the MCT level in AS was significantly increased compared to others, and the appropriate cutoff value for postmortem diagnosis of AS was 63.0 μg/L (sensitivity 88.9%, specificity 98.6%). Conclusively, serum MCT analysis is a useful test for postmortem diagnosis of AS and seems to be more appropriate for screening rather than confirmation.

REFERENCES

1. Rutkowski K, Dua S, Nasser S. Anaphylaxis: current state of knowledge for the modern physician. Postgrad Med J. 2012; 88:458–64.
crossref
2. Da Broi U, Moreschi C. Postmortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int. 2011; 204:1–5.
crossref
3. Byard RW. An analysis of possible mechanisms of unexpected death occurring in hydatid disease (echinococcosis). J Forensic Sci. 2009; 54:919–22.
crossref
4. Nara A, Aki T, Funakoshi T, et al. Death due to blood transfusion-induced anaphylactic shock: a case report. Leg Med (Tokyo). 2010; 12:148–50.
crossref
5. Belton AL, Chira T. Fatal anaphylactic reaction to hair dye. Am J Forensic Med Pathol. 1997; 18:290–2.
crossref
6. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000; 53:273–6.
crossref
7. Beck SC, Wilding T, Buka RJ, et al. Biomarkers in human anaphylaxis: a critical appraisal of current evidence and perspectives. Front Immunol. 2019; 10:494.
crossref
8. Edston E, van Hage-Hamsten M. beta-Tryptase measurements postmortem in anaphylactic deaths and in controls. Forensic Sci Int. 1998; 93:135–42.
9. Mayer DE, Krauskopf A, Hemmer W, et al. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int. 2011; 212:96–101.
crossref
10. Scarpelli MP, Keller S, Tran L, et al. Postmortem serum levels of IgE and mast cell tryptase in fatal asthma. Forensic Sci Int. 2016; 269:113–8.
crossref
11. Tamura N, Farhana M, Oda T, et al. Amniotic fluid embolism: pathophysiology from the perspective of pathology. J Obstet Gynaecol Res. 2017; 43:627–32.
crossref
12. Xiao N, Li DR, Wang Q, et al. Postmortem serum tryptase levels with special regard to acute cardiac deaths. J Forensic Sci. 2017; 62:1336–8.
crossref
13. Sun KJ, He JT, Huang HY, et al. Diagnostic role of serum tryptase in anaphylactic deaths in forensic medicine: a systematic review and meta-analysis. Forensic Sci Med Pathol. 2018; 14:209–15.
crossref
14. Tse R, Wong CX, Kesha K, et al. Post mortem tryptase cutoff level for anaphylactic death. Forensic Sci Int. 2018; 284:5–8.
crossref

Fig. 1.
Comparison of mast cell tryptase level among groups according to cause of death. AS, anaphylactic shock; IHD, ischemic heart disease; SIDS, sudden infant death syndrome; AFE, amniotic fluid embolism.
kjlm-44-17f1.tif
Fig. 2.
Receiver operating characteristic (ROC) curve for mast cell tryptase levels to diagnose anaphylactic shock.
kjlm-44-17f2.tif
Table 1.
Anaphylactic shock cases
Case No. Sex Age (yr) PMI (hr) Mast cell tryptase (μg/L) K+ (mEq/L) Allergen
Peripheral blood Heart blood
1 M 65 72 77.5 - >15 Bee sting
2 M 56 40 232 - - Ranitidine
3 M 2 78 100.4 56. - Cefotaxime
4 F 68 40 272.4 - 11.6 Cefradine
5 F 70 45 208.5 - 13.7 Ceftriaxone
6 F 48 18 9.8 4.1 8.9 Bee sting
7 M 57 66 191.9 141.5 >15 Bee sting
8 F 56 36 294.5 272.3 13.1 Bee sting
9 M 58 46 88.8 73.8 14.4 Bee sting

PMI, postmortem interval.

Table 2.
Comparison between peripheral blood and heart blood on the mast cell tryptase concentration
P/H No. (%)
<0.25 5 (3.8)
0.25-0.5 14 (10.5)
0.5-1.0 29 (21.8)
1.0-2.0 61 (45.9)
2.0-4.0 21 (15.8)
>4.0 3 (2.2)
Total 133

P/H, ratio of peripheral blood and heart blood.

Table 3.
Comparison of mast cell tryptase level among groups according to COD
COD No. Mean±SD (μg/L) Median (IQR) (μg/L) Range (μg/L) P-value a)
AS 9 164.0±98.2 191.9 (169.0) 9.8-294.5
IHD 76 10.3±18.4 6.4 (4.7) 0.1-146.7
Head injury 22 7.9±5.7 6.6 (4.5) 1.0-27.2
SIDS 9 2.9±2.7 2.0 (3.7) 0.0-8.8 <0.001
Asthma 3 4.7±1.9 4.1 3.1-6.8
AFE 2 11.7±10.3 11.7 4.4-18.9
Control 178 10.4±20.5 5.9 (7.5) 0.0-233.0

COD, cause of death; SD, standard deviation; IQR, interquartile range; AS, anaphylactic shock; IHD, ischemic heart disease; SIDS, sudden infant death syndrome; AFE, amniotic fluid embolism.

a) P-values were determined with use of the Kruskal-Walis test.

Table 4.
Analysis of variables affecting on postmortem mast cell tryptase concentration
Variable No. Value P-value
Sex   Median (IQR) (μg/L)  
 Male 208 6.15 (6.20) 0.796
 Female 82 5.85 (6.53)  
    Correlation coefficient  
Age 289 0.102 0.085
PMI 266 0.094 0.127
K+ 171 0.158 0.039

P-value for sex was determined with use of the Mann-Whitney U test. P-values for age, PMI, and K+ were determined with use of Spearman correlation.

IQR, interquartile range; PMI, postmortem interval.

Table 5.
Sensitivity and specificity of postmortem mast cell tryptase anlysis for anaphylactic shock diagnosis
Mast cell tryptase level (μg/L) Sensitivity Specificity
>11.4 0.889 0.817
>20 0.889 0.931
>30 0.889 0.972
>40 0.889 0.976
>50 0.889 0.979
>60 0.889 0.983
>70 0.889 0.986
>80 0.778 0.986
>90 0.667 0.990
>100 0.667 0.993
Table 6.
False-positive cases
Case No. Sex Age (yr) PMI (hr) Mast cell tryptase (μg/L) K+ (mEq/L) Cause of death
Peripheral blood Heart blood
1 F 53 41 64.6 - 12.2 Ischemic heart disease
2 F 57 54 82.7 24.8 >15 Nontraumatic ICH
3 M 47 38 99.7 73.8 >15 Drowning
4 M 50 25 146.7 4.1 9.0 Ischemic heart diease
5 F 32 30 233 - 10.2 Drowning
6 M 74 39 27.2 71.3 13.3 Head injury
7 M 84 43 5.9 94.9 >15 Head injury
8 M 51 50 4 108.7 >15 Nontraumatic ICH
9 M 33 - 9 262.9 - Multiple injury d/t fall

PMI, postmortem interval; ICH, intracerebral hemorrhage.

TOOLS
Similar articles